Hate ads?! Subscribe for just $5 a month!

pew report black

Hate ads?! Subscribe for just $5 a month!

RFK Jr., Dennis Quaid Announce New HHS Push on Lyme, Tick-Borne Disease

Listen to Article

RFK Jr.’s new HHS initiative on Lyme and tick-borne disease is more than a public-health announcement—it’s a rare moment when a Kennedy is openly challenging the institutional inertia that has long downplayed chronic illness. By teaming with Dennis Quaid, whose family has lived the diagnostic nightmare, the effort spotlights how federal agencies have historically treated persistent symptoms as “medically unexplained” rather than evidence of an under-researched pathogen. For the 2A community, the parallel is obvious: just as decades of CDC guidance once dismissed the idea that Lyme could survive standard antibiotic courses, the same agencies spent years insisting “assault weapons” were the sole driver of violence while ignoring mental-health failures and urban gang dynamics. When government scientists finally admit they may have mischaracterized an entire disease category, it undercuts the reflexive trust that often props up restrictions on law-abiding gun owners.

The timing matters. A fresh federal spotlight on tick-borne illness could redirect grant money toward longitudinal studies, outdoor exposure data, and perhaps even landowner incentives for habitat management—policies that intersect with the rural and hunting constituencies that form the backbone of gun culture. If HHS begins to quantify how chronic Lyme depresses workforce participation or limits time spent managing land, Second Amendment advocates gain another data point against one-size-fits-all “public-health” arguments that treat any risk as sufficient grounds for restricting access to firearms. Conversely, should the effort stall in the same regulatory thicket that has slowed Lyme research for thirty years, it will reinforce the broader case for decentralizing health policy and restoring individual responsibility—the same principle that underpins shall-issue carry and constitutional carry victories across the states.

Ultimately, the announcement is less about ticks than about credibility. When an agency publicly questions its own past assurances on a complicated medical issue, it invites scrutiny of every other domain where it claims near-infallible expertise, including the recurring claim that “more guns equal more crime.” For 2A supporters, the lesson is to treat federal health pronouncements with the same evidentiary skepticism they already apply to gun-control studies: demand raw data, independent replication, and an acknowledgment that real-world outcomes are seldom as simple as the models predict.

Share this story